Profile data is unavailable for this security.
About the company
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, and OviTex LPR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
- Revenue in USD (TTM)63.15m
- Net income in USD-40.30m
- Incorporated2012
- Employees227.00
- LocationTELA Bio Inc1 Great Valley Parkway, Suite 24MALVERN 19355United StatesUSA
- Phone+1 (484) 320-2930
- Fax+1 (302) 655-5049
- Websitehttp://www.telabio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asensus Surgical Inc | 8.72m | -78.71m | 90.41m | 207.00 | -- | 6.93 | -- | 10.36 | -0.3065 | -0.3065 | 0.0339 | 0.0479 | 0.1271 | 1.79 | 13.09 | 42,144.93 | -114.63 | -71.10 | -146.89 | -79.04 | -52.04 | -71.39 | -902.25 | -1,207.71 | 0.689 | -- | 0.00 | -- | 21.02 | -18.67 | -3.80 | -- | -6.14 | -- |
| Xtant Medical Holdings Inc | 101.23m | -1.66m | 93.48m | 207.00 | -- | 1.96 | 45.69 | 0.9235 | -0.0189 | -0.0189 | 0.8019 | 0.3662 | 1.29 | 1.36 | 6.06 | 489,043.50 | -2.11 | -10.38 | -2.98 | -14.68 | 61.47 | 61.08 | -1.64 | -8.66 | 0.978 | -4.14 | 0.3638 | -- | 57.50 | 4.81 | 107.78 | -- | 18.47 | -- |
| Myomo Inc | 19.55m | -9.34m | 97.68m | 101.00 | -- | 8.95 | -- | 5.00 | -0.2676 | -0.2676 | 0.5775 | 0.3786 | 1.29 | 3.23 | 12.10 | 193,552.80 | -61.73 | -81.78 | -89.94 | -115.27 | 67.39 | 68.50 | -47.77 | -85.76 | 2.40 | -- | 0.00 | -- | 23.70 | 51.09 | 24.00 | -- | 2.82 | -- |
| Akoya Biosciences Inc | 93.57m | -68.01m | 101.24m | 330.00 | -- | 3.09 | -- | 1.08 | -1.47 | -1.47 | 1.99 | 0.6632 | 0.6056 | 2.20 | 7.08 | 283,554.50 | -44.01 | -- | -56.06 | -- | 55.99 | -- | -72.68 | -- | 2.38 | -10.15 | 0.7013 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| KORU Medical Systems Inc | 29.32m | -13.27m | 101.60m | 82.00 | -- | 5.31 | -- | 3.46 | -0.2905 | -0.2905 | 0.6422 | 0.4181 | 0.8919 | 2.38 | 6.85 | 357,595.80 | -40.35 | -17.60 | -47.06 | -20.29 | 60.24 | 59.44 | -45.24 | -21.70 | 3.37 | -- | 0.0284 | -- | 2.23 | 10.44 | -58.65 | -- | 11.10 | -- |
| Fonar Corp | 102.72m | 10.29m | 105.16m | 561.00 | 10.58 | 0.6344 | 5.57 | 1.02 | 1.48 | 1.48 | 14.72 | 24.70 | 0.5023 | 19.99 | 1.41 | 183,098.20 | 7.16 | 8.73 | 7.40 | 9.60 | 45.55 | 48.33 | 14.26 | 16.39 | 9.16 | -- | 0.0051 | -- | 1.08 | 3.89 | -24.71 | -15.05 | 8.48 | -- |
| STRATA Skin Sciences Inc | 32.55m | -11.36m | 109.39m | 99.00 | -- | 1.16 | -- | 3.36 | -3.25 | -3.25 | 9.31 | 2.69 | 0.73 | 3.67 | 8.60 | 328,737.40 | -25.49 | -11.48 | -35.77 | -16.55 | 52.71 | 61.28 | -34.91 | -17.70 | 0.8376 | -3.90 | 0.6151 | -- | -7.75 | 2.24 | -95.17 | -- | 23.29 | -- |
| Akso Health Group - ADR | 2.20m | -17.07m | 120.30m | 12.00 | -- | -- | -- | 54.61 | -0.7466 | -0.2461 | 0.0963 | -- | 0.1166 | 1.91 | 0.3202 | 183,560.00 | -89.84 | -17.36 | -224.28 | -23.99 | 7.56 | -- | -770.59 | -256.64 | 1.36 | -24.02 | 0.6531 | -- | 119.69 | -34.25 | -221.68 | -- | -- | -- |
| Electromed Inc | 53.50m | 4.36m | 128.02m | 170.00 | 29.93 | 3.01 | 24.73 | 2.39 | 0.4942 | 0.4942 | 6.08 | 4.92 | 1.17 | 3.31 | 2.25 | 314,682.30 | 9.49 | 7.86 | 11.03 | 9.14 | 76.41 | 76.25 | 8.14 | 7.38 | 5.87 | -- | 0.00 | 0.00 | 15.38 | 11.17 | 37.35 | 11.00 | 24.58 | -- |
| TELA Bio Inc | 63.15m | -40.30m | 138.07m | 227.00 | -- | 9.60 | -- | 2.19 | -1.67 | -1.67 | 2.61 | 0.5834 | 0.9668 | 1.37 | 7.60 | 278,180.60 | -61.70 | -52.00 | -79.77 | -60.95 | 68.97 | 65.32 | -63.82 | -107.65 | 3.23 | -8.52 | 0.7387 | -- | 41.13 | 47.85 | -5.35 | -- | -17.12 | -- |
| InfuSystem Holdings Inc | 127.41m | 84.00k | 146.72m | 499.00 | 2,478.42 | 2.81 | 11.94 | 1.15 | 0.0028 | 0.0028 | 5.91 | 2.46 | 1.23 | 10.66 | 6.57 | 255,330.70 | 0.0811 | 4.60 | 0.0955 | 5.69 | 50.27 | 56.43 | 0.0659 | 4.07 | 1.51 | 1.56 | 0.3641 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
| Clearpoint Neuro Inc | 26.16m | -20.63m | 154.10m | 107.00 | -- | 4.46 | -- | 5.89 | -0.8326 | -0.8326 | 1.05 | 1.26 | 0.5037 | 1.26 | 10.08 | 244,495.30 | -39.71 | -34.75 | -49.90 | -39.67 | 57.10 | 64.75 | -78.84 | -76.91 | 2.61 | -- | 0.2237 | -- | 16.56 | 26.64 | -34.40 | -- | 75.30 | -- |
| Stereotaxis Inc | 27.10m | -21.22m | 158.68m | 122.00 | -- | 10.82 | -- | 5.85 | -0.2575 | -0.2575 | 0.3288 | 0.2439 | 0.6012 | 1.45 | 6.14 | 222,155.70 | -44.08 | -25.02 | -63.05 | -34.12 | 55.16 | 67.57 | -73.32 | -41.90 | 1.79 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| Accuray Inc | 430.55m | -21.49m | 176.65m | 1.02k | -- | 4.30 | -- | 0.4103 | -0.2197 | -0.2197 | 4.42 | 0.4139 | 0.9178 | 1.86 | 5.72 | 420,462.90 | -4.58 | -1.45 | -7.84 | -2.48 | 33.06 | 37.86 | -4.99 | -1.62 | 0.778 | -0.3857 | 0.8086 | -- | 4.12 | 2.03 | -73.56 | -- | 13.92 | -- |
| Delcath Systems Inc | 4.61m | -49.79m | 182.00m | 76.00 | -- | 11.40 | -- | 39.50 | -2.65 | -2.65 | 0.2357 | 0.5747 | 0.1382 | 0.4545 | 4.56 | 60,618.42 | -149.30 | -116.57 | -249.28 | -243.21 | 70.54 | 71.02 | -1,080.73 | -1,235.37 | 2.25 | -42.25 | 0.3348 | -- | -24.05 | -9.53 | -30.60 | -- | -5.26 | -- |
Data as of Jun 10 2024. Currency figures normalised to TELA Bio Inc's reporting currency: US Dollar USD
43.51%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| First Light Asset Management LLCas of 31 Mar 2024 | 2.75m | 11.17% |
| AIGH Capital Management LLCas of 31 Mar 2024 | 1.42m | 5.74% |
| Nantahala Capital Management LLCas of 31 Mar 2024 | 1.10m | 4.45% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 975.27k | 3.96% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 971.25k | 3.94% |
| SilverArc Capital Management LLCas of 31 Mar 2024 | 776.85k | 3.15% |
| Velan Capital Investment Management LPas of 31 Mar 2024 | 746.09k | 3.03% |
| Federated Global Investment Management Corp.as of 31 Mar 2024 | 712.30k | 2.89% |
| Stonepine Capital Management LLCas of 31 Mar 2024 | 688.20k | 2.79% |
| AWM Investment Co., Inc.as of 31 Mar 2024 | 589.96k | 2.39% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
